RediNews
ETFs Holding ARQL »    ARQL Historical Stock Prices »
ARQL News Video: Wed, Aug 15, 2018, 2:45 PM — Daily Dividend Report: STI, MMM, APC, WMB, DLR, SCI


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ArQule is a biopharmaceutical company engaged in the research and development of therapeutics to treat cancers and rare diseases. Co.'s proprietary pipeline of product candidates includes: ARQ 531, an orally bioavailable and reversible inhibitor of both wild type and C481S-mutant Bruton's tyrosine kinase for B-cell malignancies refractory to other therapeutic options; ARQ 751, an inhibitor of AKT, for solid tumors harboring the AKT1 or PI3K mutation; and ARQ 761, a B-lapachone analog being evaluated as a promoter of NQO1-mediated programmed cancer cell death for multiple oncology indications in partnership with The University of Texas Southwest Medical Center. Self directed investors in ArQule Inc. will be interested in keeping up with all ArQule Inc. news they can find, both ARQL news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on ARQL. At RediNews, we simplify this task by presenting both ARQL news releases originating from ArQule Inc. itself, and ARQL news from a variety of media outlets. Visitors can browse this news online and through our ARQL RSS news feed.

ARQL News

ARQL News — Articles, Videos, & Press Releases

Medical-Drugs Stock Outlook: No Respite from Near-Term Pain
Thursday, August 2, 2018, 3:40 PM — Zacks
Is Exelixis (EXEL) Poised for a Beat Again in Q2?
Friday, July 27, 2018, 2:03 PM — Zacks
Incyte (INCY) to Report Q2 Earnings: What's in the Cards?
Friday, July 27, 2018, 6:01 AM — Zacks
First Week of September 21st Options Trading For ArQule (ARQL)
Tuesday, July 24, 2018, 12:25 PM — Stock Options Channel
Has ArQule (ARQL) Outpaced Other Medical Stocks This Year?
Friday, July 20, 2018, 7:30 AM — Zacks
Insiders Bullish on Certain Holdings of WMCR
Thursday, July 5, 2018, 9:38 AM — ETF Channel
ARQL Crosses Above Average Analyst Target
Thursday, June 7, 2018, 7:50 AM — ETF Channel
First Week of January 2019 Options Trading For ArQule (ARQL)
Tuesday, May 22, 2018, 11:00 AM — Stock Options Channel
What's in the Cards for Merck KGaA (MKGAF) in Q1 Earnings?
Monday, May 14, 2018, 7:40 AM — Zacks
ARQL is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

CRTX News
STAA News
BABY News
MDXG News
CMN News
MDCO News
CYTX News
ACOR News
TSRO News
PBYI News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

ARQL News | www.RediNews.com | Copyright © 2013 - 2018, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.